Spectrum Pharma (SPPI) fails to win FDA panel backing

September 14, 2016 11:54 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Spectrum Pharma (NASDAQ: SPPI) fails to win FDA panel backing



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment